2023-03-30T16:58:22+08:00 weekly 1.0 https://fj.prisysbiotech.com/ 2024-11-09T21:43:15+08:00 weekly 0.9 https://fj.prisysbiotech.com/ophthalmic-disease-research 2024-11-09T21:42:57+08:00 weekly 0.9 https://fj.prisysbiotech.com/animal-welfare 2024-11-09T21:42:57+08:00 weekly 0.9 https://fj.prisysbiotech.com/metabolic-syndromes-research 2024-11-09T21:42:52+08:00 weekly 0.9 https://fj.prisysbiotech.com/translational-research-center 2024-11-09T21:42:56+08:00 weekly 0.9 https://fj.prisysbiotech.com/respiratory-disease-research 2024-11-09T21:43:03+08:00 weekly 0.9 https://fj.prisysbiotech.com/cns-disorders-behavior-analysis 2023-02-27T15:56:40+08:00 weekly 0.9 https://fj.prisysbiotech.com/co-develop 2024-11-09T21:42:57+08:00 weekly 0.9 https://fj.prisysbiotech.com/hematological-disease-research 2024-11-09T21:42:56+08:00 weekly 0.9 https://fj.prisysbiotech.com/inflammation-immunology-disorders 2026-08-08T10:22:33+08:00 weekly 0.9 https://fj.prisysbiotech.com/download 2024-09-29T14:23:03+08:00 weekly 0.9 https://fj.prisysbiotech.com/fibrosis 2024-09-29T14:45:25+08:00 weekly 0.9 https://fj.prisysbiotech.com/nephrology 2024-11-09T21:42:50+08:00 weekly 0.9 https://fj.prisysbiotech.com/about-us 2024-11-09T21:42:51+08:00 weekly 0.9 https://fj.prisysbiotech.com/contact-us 2023-04-01T09:12:04+08:00 weekly 0.9 https://fj.prisysbiotech.com/newslist-1 2024-11-09T21:42:51+08:00 weekly 0.9 https://fj.prisysbiotech.com/products 2023-04-01T09:00:32+08:00 weekly 0.9 https://fj.prisysbiotech.com/pk-pd-adme/ 2023-04-01T09:00:32+08:00 weekly 0.9 https://fj.prisysbiotech.com/safety-evaluation/ 2023-04-01T09:00:33+08:00 weekly 0.9 https://fj.prisysbiotech.com/translation-research/ 2023-04-01T09:00:33+08:00 weekly 1.0 https://fj.prisysbiotech.com/nhp-pharmacology/ 2023-04-01T09:00:36+08:00 weekly 0.9 https://fj.prisysbiotech.com/biosafety-research/ 2024-04-09T14:40:42+08:00 weekly 0.9 https://fj.prisysbiotech.com/clearpoint/ 2023-03-30T05:20:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/safety-evaluation/single-dose-repeated-dose-toxicity-testing.html 2024-11-09T21:43:03+08:00 weekly 0.8 https://fj.prisysbiotech.com/nhp-pharmacology/the-nhp-pharmacology-of-prisys.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/nhp-pharmacology/non-human-primate.html 2024-11-09T21:42:54+08:00 weekly 0.8 https://fj.prisysbiotech.com/pk-pd-adme/toxicokinetics.html 2024-11-09T21:42:50+08:00 weekly 0.8 https://fj.prisysbiotech.com/safety-evaluation/dose-range-finding-test.html 2024-11-09T21:42:52+08:00 weekly 0.8 https://fj.prisysbiotech.com/pk-pd-adme/pharmacokinetics.html 2024-11-09T21:43:05+08:00 weekly 0.8 https://fj.prisysbiotech.com/biosafety-research/biosafetyresearch.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/safety-evaluation/new-and-modified-applications.html 2024-11-09T21:42:55+08:00 weekly 0.8 https://fj.prisysbiotech.com/nhp-pharmacology/nhp-non-alcoholic-steatohepatitis-nash-model.html 2024-11-09T21:43:09+08:00 weekly 0.8 https://fj.prisysbiotech.com/nhp-pharmacology/nhp-lung-fibrosis-model.html 2024-11-09T21:42:50+08:00 weekly 0.8 https://fj.prisysbiotech.com/nhp-pharmacology/delayed-type-hypersensitivity-dth-nonhuman.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/nhp-pharmacology/coagulation-hemostasis-nonhuman-primates.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/nhp-pharmacology/non-human-primate-model-renal-ischemia.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/pk-pd-adme/adme.html 2024-11-09T21:42:59+08:00 weekly 0.8 https://fj.prisysbiotech.com/pk-pd-adme/pharmacodynamics.html 2024-11-09T21:42:48+08:00 weekly 0.8 https://fj.prisysbiotech.com/translation-research/nhpresources.html 2024-11-09T21:42:56+08:00 weekly 0.8 https://fj.prisysbiotech.com/nhp-pharmacology/nhp-asthma-atopic-dermatitis-model.html 2024-11-09T21:42:52+08:00 weekly 0.8 https://fj.prisysbiotech.com/nhp-pharmacology/hemophilia-a-nonhuman-primates-disease-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/nhp-pharmacology/nhp-chronic-obstructive-pulmonary-disease.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/safety-evaluation/toxicology.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/nhp-pharmacology/heart-failure-nonhuman-primates-disease-model.html 2024-11-09T21:42:50+08:00 weekly 0.8 https://fj.prisysbiotech.com/nhp-pharmacology/psoriasis-nonhuman-primates-disease-model.html 2024-11-09T21:42:51+08:00 weekly 0.8 https://fj.prisysbiotech.com/nhp-pharmacology/tdar-nonhuman-primates-disease-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/nhp-pharmacology/glaucoma-nonhuman-primates-disease-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/nhp-pharmacology/embolism-nonhuman-primates-disease-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/nhp-pharmacology/myopia-hyperopia-nhp-model.html 2024-11-09T21:42:54+08:00 weekly 0.8 https://fj.prisysbiotech.com/nhp-pharmacology/rheumatoid-arthritis-nhp-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/translation-research/translational-studies.html 2026-08-13T16:20:14+08:00 weekly 0.8 https://fj.prisysbiotech.com/nhp-pharmacology/what-is-a-nhp-study.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-nhp-disease-model.html 2024-11-09T21:42:51+08:00 weekly 0.8 https://fj.prisysbiotech.com/nhp-pharmacology/nhp-monkey-disease-models.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/nhp-pharmacology/uveitis-nonhuman-primates-disease-model.html 2026-08-13T16:20:25+08:00 weekly 0.8 https://fj.prisysbiotech.com/safety-evaluation/immunotoxicity.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/nhp-pharmacology/multiple-sclerosis-nhp-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/nhp-pharmacology/amd-nonhuman-primates-disease-model.html 2024-11-09T21:42:53+08:00 weekly 0.8 https://fj.prisysbiotech.com/nhp-pharmacology/mcao-nhp-model.html 2024-11-09T21:42:54+08:00 weekly 0.8 https://fj.prisysbiotech.com/nhp-pharmacology/neuropathic-pain-nhp-model.html 2024-11-09T21:43:00+08:00 weekly 0.8 https://fj.prisysbiotech.com/nhp-pharmacology/epilepsy-nhp-model.html 2024-11-09T21:42:59+08:00 weekly 0.8 https://fj.prisysbiotech.com/translation-research/ai-based-nhp-behavior-analysis-system.html 2024-11-09T21:43:00+08:00 weekly 0.8 https://fj.prisysbiotech.com/clearpoint/clearpoint-navigation-for-cns-research.html 2024-11-09T21:42:52+08:00 weekly 0.8 https://fj.prisysbiotech.com/nhp-pharmacology/parkinson-s-disease-model.html 2024-11-09T21:42:58+08:00 weekly 0.8 https://fj.prisysbiotech.com/translation-research/clinical-imaging.html 2024-10-01T13:06:22+08:00 weekly 0.8 https://fj.prisysbiotech.com/nhp-pharmacology/a-v-shunt-model.html 2024-10-01T13:06:32+08:00 weekly 0.8 https://fj.prisysbiotech.com/nhp-pharmacology/immunosuppression-model.html 2024-10-01T13:06:34+08:00 weekly 0.8 https://fj.prisysbiotech.com/nhp-pharmacology/renal-fibrosis-model.html 2024-10-01T13:29:47+08:00 weekly 0.8 https://fj.prisysbiotech.com/nhp-pharmacology/hyperlipoidemia-model.html 2024-10-01T13:29:49+08:00 weekly 0.8 https://fj.prisysbiotech.com/nhp-pharmacology/type-1-diabetes-mellitus-model.html 2024-11-09T21:42:47+08:00 weekly 0.8 https://fj.prisysbiotech.com/nhp-pharmacology/type-2-diabetes-mellitus-model.html 2024-10-01T13:29:51+08:00 weekly 0.8 https://fj.prisysbiotech.com/nhp-pharmacology/endometriosis-model.html 2024-12-07T16:07:42+08:00 weekly 0.8 https://fj.prisysbiotech.com/clearpoint/nhp-neuroscience.html 2024-12-07T17:22:10+08:00 weekly 0.8 https://fj.prisysbiotech.com/clearpoint/convection-enhanced-delivery-ced-technology.html 2025-04-01T18:32:51+08:00 weekly 0.8 https://fj.prisysbiotech.com/nhp-pharmacology/atopic-dermatitis-nhp-model.html 2025-04-01T19:06:53+08:00 weekly 0.8 https://fj.prisysbiotech.com/nhp-pharmacology/pruritus-nhp-model.html 2025-07-24T15:11:31+08:00 weekly 0.8 https://fj.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-disease-ibd-nhp-model.html 2025-07-24T15:11:39+08:00 weekly 0.8 https://fj.prisysbiotech.com/translation-research/targeted-organ-drug-delivery-platform-in-nhp.html 2025-08-25T07:49:24+08:00 weekly 0.8 https://fj.prisysbiotech.com/nhp-pharmacology/aav-synuclein-overexpression-nhp-model.html 2025-09-15T11:12:27+08:00 weekly 0.8 https://fj.prisysbiotech.com/nhp-pharmacology/heart-failure-nhp-model.html 2025-09-22T03:13:11+08:00 weekly 0.8 https://fj.prisysbiotech.com/nhp-pharmacology/acute-lung-inflammation-ali-nhp-model.html 2025-09-28T21:53:32+08:00 weekly 0.8 https://fj.prisysbiotech.com/pk-pd-adme/nose-to-brain-drug-delivery.html 2025-10-05T21:45:38+08:00 weekly 0.8 https://fj.prisysbiotech.com/nhp-pharmacology/acute-hemorrhagic-shock-model-nhp-model.html 2025-12-25T19:29:43+08:00 weekly 0.8 https://fj.prisysbiotech.com/nhp-pharmacology/retinitis-pigmentosa-rp-nhp-model.html 2026-01-29T22:43:55+08:00 weekly 0.8 https://fj.prisysbiotech.com/nhp-pharmacology/liver-fibrosis-model.html 2026-04-28T17:03:42+08:00 weekly 0.8 https://fj.prisysbiotech.com/pk-pd-adme/nhp-intracerebral-injection-icm-services.html 2026-04-28T17:03:46+08:00 weekly 0.8 https://fj.prisysbiotech.com/translation-research/dsa-guided-interventional-platform.html 2026-04-28T17:03:43+08:00 weekly 0.8 https://fj.prisysbiotech.com/pk-pd-adme/nhp-intrathecal-dosing-csf-sampling.html 2026-04-28T17:03:46+08:00 weekly 0.8 https://fj.prisysbiotech.com/translation-research/biodistribution-imaging-service.html 2026-05-25T18:08:03+08:00 weekly 0.8 https://fj.prisysbiotech.com/nhp-pharmacology/nhp-focal-segmental-glomerulosclerosis-fsgs.html 2026-05-25T18:23:43+08:00 weekly 0.8 https://fj.prisysbiotech.com/pk-pd-adme/nhp-intracerebroventricular-icv-injection.html 2023-04-01T09:00:32+08:00 weekly 0.9 https://fj.prisysbiotech.com/newslist-714382-1 2023-04-01T09:00:33+08:00 weekly 0.9 https://fj.prisysbiotech.com/newslist-714383-1 2024-08-02T08:38:40+08:00 weekly 0.9 https://fj.prisysbiotech.com/newslist-819774-1 2026-04-28T16:49:39+08:00 weekly 0.9 https://fj.prisysbiotech.com/newslist-17849998030070784-1 2026-09-01T20:50:46+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/prisys-biotech-non-human-primate-pharmacology-66136736.html 2026-09-10T15:42:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/the-construction-of-prisys-shanghai-nhp-r-d-ce-66136737.html 2026-09-10T15:42:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/meetprisys-sot2023-66136738.html 2026-09-10T15:42:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/prisys-sot2023-66136739.html 2026-09-10T15:42:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/prisys-celebrating-world-wildlife-day-66136740.html 2026-09-01T20:50:32+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/gene-therapy-nhp-model-66136741.html 2026-09-01T20:50:29+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/do-we-need-further-studies-for-pain-assessment-66136742.html 2026-09-01T20:50:31+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/top-10-popular-questions-related-to-gene-thera-66136743.html 2026-09-01T20:50:29+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/dmpk-study-for-gene-therapy-66136747.html 2026-09-10T15:42:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/supporting-women-s-health-a-look-into-endomet-66137085.html 2026-09-01T20:50:29+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/gene-therapy-toxicology-66274793.html 2026-09-01T20:50:31+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/unleashing-the-therapeutic-potential-67553743.html 2026-09-01T20:50:36+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/maximizing-sirna-pharmacology-efficiency-67561385.html 2026-09-10T15:42:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/world-parkinsons-disease-day-67561387.html 2026-09-01T20:50:32+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/how-nonhuman-primates-can-revolutionize-sirna-67565092.html 2026-09-10T15:42:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/celebrating-world-day-for-laboratory-animals-67571054.html 2026-09-01T20:50:30+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/nhp-effectively-in-gene-therapy-67571981.html 2026-09-01T20:50:33+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/unlocking-the-potential-of-nonhuman-primates-67577655.html 2026-09-01T20:50:32+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/maximizing-crispr-cas9-research-efficiency-wit-67578340.html 2026-09-10T15:42:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/meet-prisys-biotech-at-70th-jalas-68131386.html 2026-09-01T20:50:33+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/revolutionizing-drug-discovery-nhp-68131387.html 2026-09-01T20:44:18+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/why-you-should-care-about-non-human-primates-68131389.html 2026-09-01T20:50:32+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/gene-therapy-shines-with-new-approvals-for-rar-68131393.html 2026-09-01T20:44:20+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/an-optimal-animal-model-of-ischemic-stroke-est-68306204.html 2026-09-01T20:44:24+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/how-aav-gene-therapy-can-save-your-vision-the-69026942.html 2026-09-01T20:44:26+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/what-are-lipid-nanoparticles-for-gene-therapy-69027189.html 2026-09-01T20:44:27+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/immunotoxicity-test-drug-safety-evaluation-pr-69028547.html 2026-09-01T20:44:21+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/prisys-biotech-showcases-non-human-primate-mod-69028847.html 2026-09-01T20:44:41+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/the-promising-future-of-aav-gene-therapy-in-no-69029651.html 2026-09-10T15:42:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/prisys-biotech-invites-you-to-participate-in-t-69030322.html 2026-09-01T20:50:41+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/how-to-lose-weight-and-control-diabetes-with-g-69309299.html 2026-09-01T20:44:25+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/what-is-the-efficiency-of-rnai-69309314.html 2026-09-01T20:44:25+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/large-animal-experiment-public-service-platfor-69309348.html 2026-09-01T20:50:35+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/how-china-monkey-help-to-conduct-preclinical-r-69309369.html 2026-07-20T22:31:11+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/key-research-points-of-adc-drug-pk-69663531.html 2026-09-10T15:42:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/prisys-biotechnology-a-leader-in-nhp-cns-dise-69664238.html 2026-09-01T20:44:25+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/0-71000374.html 2026-09-01T20:44:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/preclinical-pharmacology-evaluation-of-oncolyt-71001288.html 2026-09-01T20:44:41+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/pharmacology-main-parameters-and-significance-71001843.html 2026-09-01T20:44:24+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/prisys-providing-high-quality-animal-experime-71003294.html 2026-09-01T20:44:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/pharmacokinetics-research-strategies-and-case-71004803.html 2026-09-01T20:44:26+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/method-for-establishing-a-cynomolgus-monkey-mo-71005255.html 2026-09-10T15:42:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/prisys-biotech-invites-you-to-attend-sapa-chin-72331934.html 2026-09-01T20:44:34+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/world-stroke-day-focus-on-ischemic-stroke-an-72331935.html 2026-09-01T20:44:24+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-macaque-animal-mod-72331936.html 2026-09-01T20:44:24+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/world-alzheimer-s-day-the-challenges-and-sol-72331937.html 2026-09-10T15:42:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/meet-prisys-biotech-at-the-society-for-neurosc-72331938.html 2026-09-10T15:42:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/exhibition-review-prisys-biotech-shines-at-t-72713378.html 2026-09-01T20:50:39+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/non-human-primates-a-brief-introduction-to-th-73030908.html 2026-09-01T20:50:34+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/how-ultrasound-guided-liver-biopsy-enhances-ma-73818338.html 2026-09-01T20:50:34+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/guidelines-for-lifetime-use-of-nonhuman-primat-73818339.html 2026-07-20T22:31:16+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/revolutionizing-cns-drug-delivery-prisys-and-74247558.html 2026-09-01T20:50:37+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/elevating-nucleic-acid-therapeutics-through-cu-74704427.html 2026-09-01T20:50:38+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/prisys-advancing-animal-experimentation-throu-74816080.html 2026-09-01T20:50:37+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/nonhuman-primate-study-newsletter-2024-q-75177815.html 2026-09-01T20:44:26+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/non-clinical-pharmacodynamics-research-an-ess-75177819.html 2026-09-01T20:50:34+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/prisys-achieves-full-accreditation-from-aaalac-76245506.html 2026-09-10T15:42:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/innovative-solutions-for-advancing-respiratory-77092047.html 2026-09-01T20:50:45+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/mri-guided-large-animal-central-nervous-system-77791074.html 2024-11-09T21:42:46+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/prisys-biotech-2024-q2-newsletter-77791083.html 2026-09-01T20:44:33+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/direct-delivery-of-oligonucleotide-drugs-to-th-79205676.html 2026-09-01T20:44:33+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/intra-cerebrovascular-stroke-ich-model-prisys-79205677.html 2026-09-01T20:44:42+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/non-na-ve-nhps-in-preclinical-trials-a-cost-e-79205687.html 2026-09-01T20:44:35+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/nhp-asthma-model-79205695.html 2026-09-01T20:44:33+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/advancing-immunology-and-inflammation-research-79205698.html 2026-09-01T20:44:30+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/cynomolgus-monkey-in-ophthalmic-drug-research-79514323.html 2024-11-09T21:42:46+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/revolutionizing-cns-drug-development-prisys-b-79514325.html 2026-09-01T20:44:35+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/prisys-nhp-models-immunology-inflammatio-79514326.html 2026-09-01T20:50:46+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/pk-strategies-of-pdc-79561272.html 2026-09-01T20:44:30+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/preclinical-animal-studies-1-animal-specie-79561273.html 2026-09-01T20:50:50+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/nonclinical-safety-evaluation-of-ocular-drug-d-79561274.html 2026-09-01T20:44:32+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/clinical-pathology-data-interpretation-challen-79561275.html 2026-09-01T20:50:37+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/integrating-cns-safety-evaluation-into-79561276.html 2026-09-01T20:44:34+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/preclinical-animal-studies-2-routes-and-vo-79561277.html 2026-09-01T20:50:40+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/reducing-the-use-of-nonhuman-primates-in-noncl-79561278.html 2026-09-01T20:44:37+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/advancing-cns-and-cgt-research-prisys-biotech-79561279.html 2026-09-01T20:50:41+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/optimized-nonclinical-immunogenicity-evaluatio-79561280.html 2026-09-01T20:44:35+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/considerations-for-interpreting-clinical-patho-79561281.html 2026-09-01T20:44:38+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/reflections-on-non-clinical-pharmacology-studi-79561282.html 2026-09-01T20:44:30+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79561283.html 2026-09-01T20:50:44+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/the-role-of-aav-in-gene-therapy-immune-respon-79561284.html 2026-09-01T20:44:52+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/advancing-sirna-therapeutics-overcoming-chall-79561285.html 2026-09-01T20:44:37+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79561286.html 2026-09-01T20:44:41+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/non-human-primate-cerebrospinal-fluid-collecti-79561287.html 2026-09-01T20:44:48+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/application-prospects-of-gene-drugs-based-on-l-79561288.html 2026-09-01T20:44:42+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/insight-into-the-sensory-and-behavioral-traits-79561289.html 2026-09-01T20:44:41+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/how-to-evaluate-preclinical-pharmacological-ef-79561290.html 2026-09-01T20:44:40+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/nonclinical-study-evaluation-q-a-79561291.html 2026-09-01T20:45:05+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/liver-toxicity-as-a-key-concern-for-sirna-drug-79561292.html 2026-09-01T20:50:17+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/how-to-evaluate-the-safety-of-skin-products-be-79561293.html 2026-09-01T20:44:40+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/key-points-in-designing-strategies-for-non-79561294.html 2026-09-01T20:44:37+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/how-to-conduct-preclinical-pharmacology-toxico-79561295.html 2026-09-01T20:50:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/the-vital-role-of-experimental-monkeys-in-adva-79561296.html 2026-09-01T20:50:22+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/how-drugs-move-and-change-in-our-bodies-a-bri-79561297.html 2026-09-01T20:50:17+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/revolutionizing-metabolic-disease-treatment-a-79561298.html 2026-09-01T20:50:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/how-to-develop-new-drugs-faster-and-safer-a-g-79561299.html 2026-09-01T20:50:32+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/group-housing-guidelines-for-laboratory-monkey-79561300.html 2026-09-01T20:44:49+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/significance-principles-and-requirements-of-79561301.html 2026-09-01T20:50:40+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/chinese-scientists-offers-new-strategies-to-re-79561303.html 2026-09-01T20:50:25+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/the-importance-of-translational-medicine-resea-79561304.html 2026-09-01T20:50:21+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/understanding-macaca-fascicularis-cynomolgus-79561305.html 2026-09-01T20:50:40+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79561306.html 2026-09-01T20:50:43+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/pharmacodynamic-pd-evaluation-of-gene-therap-79561307.html 2026-09-01T20:50:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/how-to-deliver-biologics-to-the-brain-79561308.html 2026-09-01T20:50:44+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/factors-to-consider-for-the-immunogenicity-of-79561309.html 2026-09-01T20:45:10+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/the-significant-role-of-experimental-monkeys-i-79561310.html 2026-09-01T20:50:41+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79561311.html 2026-09-01T20:50:40+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/mrna-based-therapies-past-79561312.html 2026-09-01T20:50:25+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/prisys-biotechnology-novel-lipid-nanoparticle-79561313.html 2026-09-01T20:50:44+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/mrna-based-therapies-present-79561314.html 2026-09-01T20:50:43+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/lcms-preclinical-bioanalysis-of-lnp-based-gene-79561315.html 2026-09-01T20:50:29+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/brief-introduction-about-biological-analysis-o-79561316.html 2026-09-01T20:50:29+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/mrna-based-therapies-future-and-challenges-79561317.html 2026-09-01T20:50:22+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/the-main-factors-considered-in-woe-analysis-79561318.html 2026-09-01T20:50:41+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/mrna-a-powerful-and-versatile-tool-for-fighti-79561319.html 2026-09-01T20:50:46+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/advancements-in-cns-research-ced-imri-79656500.html 2026-09-01T20:50:43+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/intranasal-administration-in-animal-studies-81262532.html 2026-09-01T20:50:44+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/advanced-cns-delivery-techniques-in-cynomolgus-81262533.html 2026-09-01T20:50:30+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/human-disease-animal-models-81262534.html 2026-09-01T20:50:52+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/convection-enhanced-delivery-81262535.html 2026-09-01T20:50:30+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/animal-models-of-human-diseases-81262536.html 2026-09-01T20:50:32+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/china-experimental-monkey-industry-81262537.html 2026-09-01T20:50:46+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/cynomolgus-monkey-chronic-kidney-disease-model-81262538.html 2026-09-01T20:50:29+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/dmpk-evaluation-of-central-nervous-system-cns-81262539.html 2026-09-01T20:50:38+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/compartment-pk-model-81262540.html 2026-09-01T20:50:28+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/rtimri-for-parkinsons-disease-81262541.html 2026-09-01T20:50:41+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/innovations-in-pain-evaluation-ai-driven-beha-81262542.html 2026-09-01T20:50:49+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/cynomolgus-monkey-mcao-model-81262543.html 2026-09-01T20:50:48+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/the-importance-of-preclinical-pharmacodynamics-81262544.html 2026-09-01T20:50:31+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/advances-in-mrna-pulmonary-delivery-systems-an-82290098.html 2026-09-01T20:50:49+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/pharmacodynamics-evaluation-of-adcs-82741012.html 2026-09-01T20:50:55+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/prisys-biotech-establishes-cynomolgus-monkey-p-82741013.html 2026-09-01T20:50:46+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/pharmacokinetics-evaluation-of-antibody-drug-c-82741015.html 2026-09-01T20:50:32+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/2024-nobel-prize-in-physiology-or-medicine-82741016.html 2026-09-01T20:50:41+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/pharmacokinetic-pk-considerations-for-centra-82741017.html 2026-09-01T20:50:56+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/understanding-the-dmpk-of-adc-drugs-82741022.html 2026-09-01T20:51:01+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/comprehensive-non-human-primate-models-for-ren-82741026.html 2026-09-01T20:50:48+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/comprehensive-preclinical-safety-evaluation-of-82741035.html 2026-09-01T20:51:01+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/progress-in-the-development-of-nucleic-acid-dr-82741985.html 2026-09-01T20:50:59+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/ocular-toxicity-studies-of-eye-drops-drug-exp-83024487.html 2026-09-01T20:50:47+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/real-time-intraoperative-mri-navigation-suppo-83026548.html 2026-09-01T20:50:54+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/drug-delivery-strategies-for-brain-diseases-83040807.html 2026-09-01T20:50:52+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/minipig-as-nonclinical-large-animal-83980374.html 2026-09-10T15:42:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/nasal-to-brain-n2b-drug-delivery-83980375.html 2026-09-01T20:50:51+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/nonclinical-drug-development-guide-toxicity-83980377.html 2026-09-01T20:50:53+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/potential-routes-for-biologics-to-brain-83980380.html 2026-09-01T20:50:55+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/parkin-gene-deficiency-monkey-model-reveals-ne-83980386.html 2026-09-01T20:50:51+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/animal-models-for-atopic-dermatitis-83980392.html 2026-09-10T15:42:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/the-critical-role-of-animal-models-in-human-di-83980407.html 2026-09-10T15:42:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/advancing-rheumatoid-arthritis-ra-research-w-83982657.html 2026-09-10T15:42:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/prisys-annual-report-2024-advancing-nhp-model-83982659.html 2026-09-10T15:42:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/meet-prisys-in-2025-us-roadshow-17243258411508736.html 2026-09-01T20:51:04+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/selecting-the-ideal-non-human-primate-for-toxi-17243258490266624.html 2026-07-20T22:39:01+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/animal-brain-stereotactic-instruments-17295205351384064.html 2026-09-10T15:42:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/integration-of-pharmacokinetics-and-pharmacody-17295205373486080.html 2026-09-01T20:50:50+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/systemic-lupus-erythematosus-sle-and-the-rol-17295205390853120.html 2026-09-01T20:51:04+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/animal-models-challenges-and-applications-in-17295205446460416.html 2026-09-01T20:50:53+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/microbial-testing-and-its-impact-on-nhp-17295205503968256.html 2026-07-20T22:38:47+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/animal-models-for-in-vivo-testing-1-establi-17295205565588480.html 2026-09-01T20:51:01+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/nonclinical-pharmacodynamic-research-17295205578302464.html 2026-09-01T20:51:01+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/what-does-proof-of-concept-poc-in-drug-devel-17295205583938560.html 2026-09-10T15:42:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-monkey-psoriasis-m-17295205655356416.html 2026-09-10T15:42:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/cynomolgus-monkey-endometriosis-model-17295205769520128.html 2026-09-01T20:50:53+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/pharmacokinetics-of-inhaled-drugs-17295205823161344.html 2026-09-10T15:42:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/world-obesity-day-nhp-metabolic-models-17295206030763008.html 2026-09-01T20:51:02+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/animal-models-for-womens-health-17295238880371712.html 2026-07-20T22:53:33+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/membranous-nephropathy-model-17295238933275648.html 2026-07-20T22:53:50+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/nonclinical-immunotoxicity-assessment-strateg-17295239115891712.html 2026-09-10T15:42:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/non-human-primate-model-for-rheumatoid-arthrit-17295361228088320.html 2026-07-20T22:53:33+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/targeting-interleukin-31-autoimmune-disease-17298427841831936.html 2026-09-10T15:42:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/pharmacokinetics-pk-key-parameters-17374213068334080.html 2026-07-20T22:53:42+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/intracerebroventricular-icv-injection-17374213124629504.html 2026-07-20T22:54:02+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/intracerebral-icm-injection-precision-targe-17374213177713664.html 2026-09-10T15:42:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/atopic-dermatitis-how-cynomolgus-monkey-model-17374213185905664.html 2026-09-01T20:51:02+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/asthma-research-why-non-human-primate-models-17374213241054208.html 2026-09-01T20:50:58+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/aso-pharmacokinetics-absorption-17374213290976256.html 2026-07-20T22:53:45+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/advancing-parkinson-s-disease-research-with-th-17374213315453952.html 2026-09-01T20:51:02+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/intrathecal-it-injection-a-direct-cns-deliv-17374213364261888.html 2026-07-20T23:10:50+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/nhp-inhalation-studies-for-biologics-prisys-17374213503050752.html 2026-07-20T22:53:30+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/designing-animal-studies-key-considerations-f-17374213532722176.html 2026-07-20T22:54:57+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/preclinical-pk-pd-studies-nhp-models-17374213631370240.html 2026-07-20T22:54:16+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/advanced-preclinical-inhalation-studies-techn-17374258095662080.html 2026-07-20T22:53:36+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/guiding-principles-for-animal-species-selectio-17456372650812416.html 2026-09-01T20:51:02+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/cynomolgus-monkey-pain-models-17456372663280640.html 2025-07-24T15:11:33+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/nhp-model-platforms-to-support-drug-developmen-17456372674176000.html 2025-07-24T15:11:39+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/prisys-biotech-s-nhp-atopic-dermatitis-model-f-17456372677338112.html 2026-07-20T22:53:41+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/engineered-exosomes-revolutionizing-drug-deli-17456372719903744.html 2026-09-01T20:51:12+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/prisys-biotech-s-advanced-dsa-and-imri-for-hem-17456372754473984.html 2025-07-24T15:11:49+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/nhp-pain-models-accelerating-analgesic-drug-d-17456372825957376.html 2025-07-24T15:11:38+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/prisys-biotech-2025-mid-year-review-17456372831593472.html 2025-07-24T15:11:42+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/advancing-atopic-dermatitis-research-prisys-b-17456372851549184.html 2026-07-20T23:10:47+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/key-considerations-for-dosing-volume-17456372870341632.html 2026-07-20T22:53:32+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/a-guide-to-anti-drug-antibody-ada-assessment-17456373371413504.html 2026-09-01T20:51:09+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/respiratory-therapies-prisys-biotech-s-integr-17456383667102720.html 2026-09-10T15:42:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/pruritus-research-il-31-nhp-itch-model-17501210434380800.html 2026-09-10T15:42:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/nhp-acute-hemorrhage-model-17501210452796416.html 2026-09-10T15:42:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/nhp-copd-model-17501210513908736.html 2026-09-01T20:51:20+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/preclinical-dosing-guidelines-iv-po-volume-17501210543809536.html 2026-09-10T15:42:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/nhp-pain-models-for-translational-drug-discove-17501210683810816.html 2026-09-01T20:51:25+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/serum-vs-plasma-choosing-the-optimal-matrix-17501210849600512.html 2026-09-10T15:42:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/brain-targeted-drug-delivery-17531135406384128.html 2026-09-10T15:42:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/the-importance-of-administration-volume-17531135440987136.html 2026-09-01T20:56:37+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/cynomolgus-monkey-biodistribution-study-17531135489696768.html 2026-09-10T15:42:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/idiopathic-pulmonary-fibrosis-ipf-nhp-model-17531135604827136.html 2026-07-20T22:53:49+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/adc-drug-development-translational-pk-pd-fra-17531135680078848.html 2026-09-10T15:42:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/nhp-models-for-hematology-and-stroke-17531135734817792.html 2026-09-10T15:42:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/meet-prisys-biotech-at-upcoming-eu-roadshow-17531174428156928.html 2026-09-01T20:56:38+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/cynomolgus-rhesus-monkey-models-prisys-bio-17540597077795840.html 2026-09-10T15:42:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/nhp-based-pharmacology-and-pharmacodynamic-17560108341453824.html 2026-09-01T20:56:35+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/shr-2004-a-breakthrough-in-vte-prevention-for-17633268872881152.html 2026-09-01T20:56:34+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/cold-allodynia-pain-model-in-cynomolgus-monkey-17633268919510016.html 2026-09-10T15:42:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/nasal-to-brain-n2b-delivery-technology-for-c-17633268931273728.html 2026-07-20T22:53:47+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/th17-driven-nhp-immunology-models-17633268934648832.html 2026-09-10T15:42:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/nhp-ai-based-behavioral-analysis-17633269026268160.html 2026-09-01T20:56:44+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/pk-study-targeted-drug-delivery-17633269044470784.html 2026-09-10T15:42:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/rfp-template-for-nhp-studies-17633269086757888.html 2026-09-01T20:56:35+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/mri-guided-intracerebral-drug-delivery-17633269111809024.html 2026-09-10T15:42:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/ai-based-nhp-behavioratlas-system-3d-behavi-17633269136401408.html 2026-07-20T22:53:48+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/nhp-renal-biopsy-17633269159977984.html 2026-09-10T15:42:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/nhp-respiratory-disease-models-and-airway-drug-17633269294867456.html 2026-09-10T15:42:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/translational-car-t-evaluation-in-vitro-17674636216411136.html 2026-09-10T15:42:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/ai-driven-markerless-3d-behavioral-analysis-17674636225995776.html 2026-09-10T15:42:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/high-precision-drug-delivery-and-ai-driven-nhp-17674636268151808.html 2026-09-10T15:42:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/hdm-seb-induced-atopic-dermatitis-atd-model-17674636302017536.html 2026-09-10T15:42:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/lps-induced-acute-lung-inflammation-ali-nhp-17674636312175616.html 2026-07-20T23:10:54+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/cns-drug-candidates-in-preclinical-study-17674636324840448.html 2026-09-01T20:56:50+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/how-to-choose-a-reliable-preclinical-cro-key-17674636489532416.html 2026-07-20T22:54:55+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/parkinsons-disease-preclinical-models-17674636566176768.html 2025-12-25T19:49:46+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/one-to-multi-compartment-pk-models-17674643909141504.html 2026-01-29T22:43:47+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/non-human-primate-mash-associated-liver-fibros-17724350425687040.html 2026-01-29T22:43:54+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/multi-endpoint-pain-assessment-the-future-17724350458766336.html 2026-01-29T22:43:56+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/2025-recap-how-prisys-is-redefining-translati-17724350479148032.html 2026-01-29T22:45:01+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/emotional-memory-chronic-pain-nhp-models-17724350505624576.html 2026-01-29T22:44:01+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/non-human-primate-models-are-critical-cns-17724350579287040.html 2026-01-29T22:43:52+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/analgesics-fail-in-preclinical-measure-pain-17724350616331264.html 2026-01-29T22:43:56+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/imri-guided-brain-drug-delivery-17724350620967936.html 2026-01-29T22:43:54+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/blood-sampling-time-point-in-pharmacokinetic-17724350687667200.html 2026-01-29T22:44:01+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/pk-statistical-analysis-nca-parameters-guide-17724350705853440.html 2026-01-29T22:43:51+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/uric-acid-metabolism-in-humans-vs-monkeys-17724350740653056.html 2026-04-28T16:49:50+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/ipf-drug-development-nhp-ct-imaging-pft-17849998145954816.html 2026-04-28T16:49:44+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/large-animal-radiolabeling-and-in-vivo-imaging-17849998158308352.html 2026-04-28T16:49:47+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/pet-ct-biodistribution-in-nhp-models-for-cns-17849998159242240.html 2026-04-28T16:49:53+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/evaluating-dmpk-properties-17849998177936384.html 2026-04-28T16:49:54+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/prisys-supports-ind-approval-of-ux-gip001-17849998224827392.html 2026-04-28T16:49:48+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/nhp-cns-biodistribution-studies-intrathecal-17849998235984896.html 2026-04-28T16:49:51+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/in-vivo-immune-cell-tracking-17849998263526400.html 2026-04-28T16:49:45+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/mri-guided-cns-delivery-in-nhp-models-17849998292526080.html 2026-04-28T16:49:47+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/translational-pk-pd-framework-cynomolgus-17849998393582592.html 2026-04-28T16:49:53+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/dopamine-transporter-pet-imaging-in-nhp-models-17849998437950464.html 2026-04-28T17:03:42+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/nhp-av-shunt-thrombosis-model-antibody-safety-17850010519413760.html 2026-04-28T17:03:45+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/non-glp-pharmacology-data-integrity-17850010598958080.html 2026-04-28T17:03:47+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/ai-markerless-nhp-3d-behavior-analysis-system-17850010613916672.html 2026-04-28T17:03:49+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/nonlinear-pharmacokinetics-nhp-pkpd-17850010697425920.html 2026-04-28T17:03:48+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/drug-development-reliance-on-nhp-models-17850010709173248.html 2026-04-28T17:03:51+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/nonclinical-pharmacokinetics-strategy-17850010732127232.html 2026-07-21T00:29:49+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/on-demand-webinar-mri-ced-nhp-17888297319408640.html 2026-05-25T18:07:54+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/nhp-models-translational-drug-development-17888297381684224.html 2026-07-21T00:30:25+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/pk-data-as-translational-biomarker-17888297445303296.html 2026-05-25T18:08:06+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/non-human-primate-models-of-pulmonary-fibrosis-17888297521406976.html 2026-05-25T18:08:12+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/pk-data-as-pharmacodynamic-biomarker-17888297671582720.html 2026-07-21T00:29:57+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/nonlinear-pharmacokinetics-explained-17934440324670464.html 2026-07-21T00:30:26+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/dsa-cta-cardiovascular-drug-safety-imaging-17934440333566976.html 2026-07-21T00:29:52+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/nhp-heart-failure-model-17934440351212544.html 2026-07-21T00:30:07+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/what-is-molecular-imaging-drug-development-17934440390190080.html 2026-07-21T00:30:17+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/molecular-imaging-biomarkers-advancing-transl-17934440477746176.html 2026-07-20T23:11:16+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/clinical-pathology-interpretation-dogs-nhp-17934440513954816.html 2026-07-21T00:30:05+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/nhp-molecular-imaging-translational-pet-studie-17934440538203136.html 2026-07-21T00:30:08+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/nhp-radionuclide-biodistribution-17934440681382912.html 2026-07-21T00:29:48+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/nhp-av-shunt-thrombosis-model-17934457971844096.html 2026-07-20T22:53:46+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/nhp-models-of-maternal-high-fat-diet-and-child-17967846573450240.html 2026-07-20T22:53:49+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/ai-nhp-behavioral-analysis-17967846589981696.html 2026-07-20T22:53:41+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/pain-mechanisms-the-uvb-sunburn-model-17967847054173184.html 2026-07-20T22:53:54+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/nhp-behavioratlas-3d-behavioral-tracking-17967847521051648.html 2026-08-23T05:48:18+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/webinar-nhp-behavioratlas-17972998528984064.html 2026-07-24T14:14:20+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/nhp-aav-gene-therapy-model-mri-guided-ced-17972998596797440.html 2026-07-24T14:14:22+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/markerless-3d-nhp-behavior-analysis-17972998687630336.html 2026-07-24T14:14:21+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/why-positive-control-drugs-matter-in-autoimmun-17972998700000256.html 2026-07-24T14:14:13+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/nhp-ibd-model-chronic-enterocolitis-17972998817309696.html 2026-07-24T14:14:23+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/baseline-ada-screening-washed-out-monkeys-17972998980740096.html 2026-07-24T14:14:27+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/when-to-introduce-nhp-studies-autoimmune-drug-17972999055074304.html 2026-07-31T20:51:13+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/behavior-in-rhesus-17983300054475776.html 2026-07-31T20:51:04+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/midd-and-nhp-efficacy-models-in-drug-17983300081476608.html 2026-08-05T18:31:48+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/pk-biomarkers-preclinical-drug-development-17990241171956736.html 2026-09-01T20:56:39+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/webinar-recap-digital-behavioral-phenotyping-17992973376447488.html 2026-09-01T20:56:43+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/molecular-imaging-in-nhp-model-webinar-18003059244786688.html 2026-09-01T20:56:40+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/pbpk-vs-compartmental-models-drug-development-18003059439789056.html 2026-09-01T20:56:38+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/3d-ai-tracking-nhp-behavior-18014972186649600.html 2026-08-23T07:06:43+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/pet-biodistribution-nhp-studies-18015049338840064.html 2026-09-01T20:56:55+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/quantitative-pet-target-engagement-in-nhps-for-18021127134028800.html 2026-09-01T11:33:20+08:00 weekly 0.8 https://fj.prisysbiotech.com/news/animal-models-succeed-or-fail-in-drug-dev-18028053867865088.html